Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Nutrition in Inflammatory Bowel Disease
Philipp Schreiner, Maude Martinho-Grueber, Diana Studerus, et al.
Digestion (2020) Vol. 101, Iss. Suppl. 1, pp. 120-135
Open Access | Times Cited: 78

Showing 1-25 of 78 citing articles:

ESPEN guideline on Clinical Nutrition in inflammatory bowel disease
Stephan C. Bischoff, Palle Bager, Johanna C. Escher, et al.
Clinical Nutrition (2023) Vol. 42, Iss. 3, pp. 352-379
Open Access | Times Cited: 178
Leaky Gut: Effect of Dietary Fiber and Fats on Microbiome and Intestinal Barrier
Haruki Usuda, Takayuki Okamoto, Koichiro Wada
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 14, pp. 7613-7613
Open Access | Times Cited: 174
Intestinal Barrier and Permeability in Health, Obesity and NAFLD
Piero Portincasa, Leonilde Bonfrate, Mohamad Khalil, et al.
Biomedicines (2021) Vol. 10, Iss. 1, pp. 83-83
Open Access | Times Cited: 143
The Role of Diet in the Pathogenesis and Management of Inflammatory Bowel Disease: A Review
Gabrielle Wark, Dorit Samocha‐Bonet, Simon Ghaly, et al.
Nutrients (2020) Vol. 13, Iss. 1, pp. 135-135
Open Access | Times Cited: 97
Not All Fibers Are Born Equal; Variable Response to Dietary Fiber Subtypes in IBD
Heather Armstrong, I K Mander, Zhengxiao Zhang, et al.
Frontiers in Pediatrics (2021) Vol. 8
Open Access | Times Cited: 77
Aktualisierte S3-Leitlinie „Diagnostik und Therapie des Morbus Crohn“ der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) – August 2021 – AWMF-Registernummer: 021-004
Andreas Sturm, Andreas Stallmach, Raja Atreya, et al.
Zeitschrift für Gastroenterologie (2022) Vol. 60, Iss. 03, pp. 332-418
Closed Access | Times Cited: 64
Dietary Patterns and Gut Microbiota Changes in Inflammatory Bowel Disease: Current Insights and Future Challenges
Jing Yan, Lei Wang, Yu Gu, et al.
Nutrients (2022) Vol. 14, Iss. 19, pp. 4003-4003
Open Access | Times Cited: 48
Ferroptosis in the colon epithelial cells as a therapeutic target for ulcerative colitis
Akihito Yokote, Noriyuki Imazu, Junji Umeno, et al.
Journal of Gastroenterology (2023) Vol. 58, Iss. 9, pp. 868-882
Closed Access | Times Cited: 25
The Role of Gluten in Gastrointestinal Disorders: A Review
Sabrina Cenni, Veronica Sesenna, Giulia Boiardi, et al.
Nutrients (2023) Vol. 15, Iss. 7, pp. 1615-1615
Open Access | Times Cited: 20
Aktualisierte S3-Leitlinie „Diagnostik und Therapie des Morbus Crohn“ der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) (Version 4.1) – living guideline
Andreas Sturm, Raja Atreya, Dominik Bettenworth, et al.
Zeitschrift für Gastroenterologie (2024) Vol. 62, Iss. 08, pp. 1229-1318
Open Access | Times Cited: 7
The effects of flaxseed supplementation on metabolic syndrome parameters, insulin resistance and inflammation in ulcerative colitis patients: An open‐labeled randomized controlled trial
Nava Morshedzadeh, Mehran Rahimlou, Shabnam Shahrokh, et al.
Phytotherapy Research (2021) Vol. 35, Iss. 7, pp. 3781-3791
Closed Access | Times Cited: 37
Adverse Food Reactions in Inflammatory Bowel Disease: State of the Art and Future Perspectives
I. Capobianco, Federica Di Vincenzo, Pierluigi Puca, et al.
Nutrients (2024) Vol. 16, Iss. 3, pp. 351-351
Open Access | Times Cited: 5
Therapeutic Potential of Palmitoylethanolamide in Gastrointestinal Disorders
Marija Branković, Tijana Gmizić, Marija Dukić, et al.
Antioxidants (2024) Vol. 13, Iss. 5, pp. 600-600
Open Access | Times Cited: 5
Nutritional Lipids and Mucosal Inflammation
Paulina Wawrzyniak, Nazek Noureddine, Marcin Wawrzyniak, et al.
Molecular Nutrition & Food Research (2020) Vol. 65, Iss. 5
Closed Access | Times Cited: 35
Inflammatory Bowel Diseases: Is There a Role for Nutritional Suggestions?
Lorenzo Bertani, Davide Giuseppe Ribaldone, Massimo Bellini, et al.
Nutrients (2021) Vol. 13, Iss. 4, pp. 1387-1387
Open Access | Times Cited: 28
Reducing Disease Activity of Inflammatory Bowel Disease by Consumption of Plant-Based Foods and Nutrients
Christian S. Antoniussen, H.H. Rasmussen, Mette Holst, et al.
Frontiers in Nutrition (2021) Vol. 8
Open Access | Times Cited: 28
Insights into diet-associated oxidative pathomechanisms in inflammatory bowel disease and protective effects of functional amino acids
Yun Ji, Ying Yang, Shiqiang Sun, et al.
Nutrition Reviews (2022) Vol. 81, Iss. 1, pp. 95-113
Closed Access | Times Cited: 22
Immunity and Nutrition: The Right Balance in Inflammatory Bowel Disease
Bartolo Tamburini, Marco Pio La Manna, Lidia La Barbera, et al.
Cells (2022) Vol. 11, Iss. 3, pp. 455-455
Open Access | Times Cited: 21
Inflammatory bowel disease therapeutic strategies by modulation of the microbiota: how and when to introduce pre-, pro-, syn-, or postbiotics?
Amélie Lê, Marine Mantel, Justine Marchix, et al.
AJP Gastrointestinal and Liver Physiology (2022) Vol. 323, Iss. 6, pp. G523-G553
Open Access | Times Cited: 19
Phase-dependent iron depletion differentially regulates the niche of intestinal stem cells in experimental colitis via ERK/STAT3 signaling pathway
Shubin Wang, Xiangjun Liu, Lu Xu, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Adherence to the Mediterranean Diet in Paediatric Patients with Inflammatory Bowel Disease and Functional Abdominal Pain Disorders—Comparative Study
Iulia Ţincu, Bianca Teodora Chenescu, Larisa Alexandra Duchi, et al.
Journal of Clinical Medicine (2025) Vol. 14, Iss. 6, pp. 1971-1971
Open Access
Role of Gut Microbiota and Metabolomics in Predicting Response to Vedolizumab in Inflammatory Bowel Disease: A Systematic Review
Vaidota Malinauskiene, Elena Cijauskaite, Goda Sadauskaite, et al.
Pharmaceutics (2025) Vol. 17, Iss. 4, pp. 476-476
Open Access
The effects of probiotic treatment with Bifidobacterium breve, Bif195 for small intestinal Crohn’s disease and the gut microbiome: results from a randomised, double-blind, placebo-controlled trial
Ida Marie Bruun Grønbæk, Sofie Ingdam Halkjær, Sarah Mollerup, et al.
Gut Pathogens (2025) Vol. 17, Iss. 1
Open Access
S3-Leitlinie Klinische Ernährung bei chronisch-entzündlichen Darmerkrankungen
Stephan C. Bischoff, Irina Blumenstein, Susanne In der Smitten, et al.
Aktuelle Ernährungsmedizin (2025) Vol. 50, Iss. 02, pp. 80-114
Closed Access
Page 1 - Next Page

Scroll to top